858 Therapeutics | The Pharmaletter
858's lead programs focus on important nodes in cancer biology, including DNA damage repair, innate immunity, and RNA epigenetics. The company’s lead asset, ETX-19477, is a novel and …
OFF
The Pharma Letter On LinkedIn: 858 Therapeutics Secures $50 …
6 days from now
858 Therapeutics secures $50 million in series B funding Read the article: ... The Pharma Letter’s Post The Pharma Letter 1,517 followers 7h Report this post ...
linkedin.com
OFF
858 Therapeutics Launches With $60 Million And Acquisition Of …
6 days from now
Sep 20, 2021 · The new company will advance Gotham’s lead epitranscriptomics program focused on METTL3. After operating for more than 2 years in stealth, the biotech startup 858 …
acs.org
OFF
858 Therapeutics Announces $50 Million Series B Financing
6 days from now
Sep 26, 2024 · In multiple animal models, ETX-19477 shows potent tumor growth inhibition, which is associated with specific genetic biomarkers. 858 Therapeutics is evaluating ETX-19477 in a …
businesswire.com
OFF
News | 858 Therapeutics
6 days from now
News. November 4, 2024 858 Therapeutics and OpenBench Launch Small Molecule Drug Discovery Collaboration. September 26, 2024 858 Therapeutics Announces $50 Million Series …
8five8tx.com
OFF
858 Therapeutics Nabs $50M Round - San Diego Business Journal
6 days from now
Oct 14, 2024 · Photo courtesy 858 Therapeutics. LA JOLLA– Torrey Pines-based 858 Therapeutics has successfully raised $50 million in Series B financing to advance its pipeline …
sdbj.com
OFF
858 Therapeutics Launches With Proven Team And $60 Million …
6 days from now
Sep 21, 2021 · About 858 Therapeutics. 858 Therapeutics is a biotechnology and drug discovery company developing a portfolio of small molecules directed against novel therapeutic targets …
businesswire.com
OFF
858 Therapeutics - PitchBook
6 days from now
1. Early Stage VC (Series A) 13-Jul-2020. $20.1M. $20.1M. Completed. Clinical Trials - General. To view 858 Therapeutics’s complete valuation and funding history, request access ».
pitchbook.com
FAQs about 858 Therapeutics | The Pharmaletter Coupon?
What is 858 Therapeutics?
When will 858 Therapeutics start a Phase 1 trial?
When will 858 Therapeutics start IND-enabling work?
Has 858 Therapeutics acquired Gotham Therapeutics?
Who is VP of Biology at 858 Therapeutics?
Can 858 help patients with intractable forms of cancer?
Install CouponFollow Extension on Chrome
Install the CouponFollow extension to search for discount codes when shopping the fastest!
Install CouponFollow Chrome Extension